Lipocine Inc LPCN
NASDAQ · United States · Health Technology
$2.10+0.03 (+1.45%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-04 | -0.32 | -0.40 | +20.0% | $190.10K | -10.8% | +2.8%$2.11→$2.17 |
| Q1 2026 | 2026-05-07 | -0.54 | -0.51 | -5.9% | — | — | -2.5%$2.43→$2.37 |
| Q4 2025 | 2026-03-10 | -0.42 | -0.61 | +31.1% | — | — | +14.1%$7.88→$8.99 |
| Q3 2025 | 2025-11-06 | -0.59 | -0.56 | -5.4% | — | — | -0.8%$2.56→$2.54 |
| Q4 2024 | 2025-03-13 | 0.33 | -0.40 | +182.5% | — | — | — |
| Q4 2023 | 2024-03-07 | -0.42 | -0.47 | +10.6% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.